🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Voted!

#ELCC25 | Come incrementare il testing rate dei marcatori predittivi di risposta nel #lungcancer tramite tecnologie di nuova generazione? Il commento di Umberto Malapelle 👇 A breve l’intervista completa su Oncoinfo 🔜 Marina Garassino Alfredo Addeo MD

Marina Garassino presents Phase 2 KRYSTAL-7: First-line adagrasib + pembrolizumab in 1st line KRASG12C-mut NSCLC & PD-L1>50% ✅ORR 59% ✅DoR 26.3 months ✅PFS 27.7 months ✅OS NR at 18 months ✅TRAEs overall manegable #ESMOAmbassadors #ELCC25 #LCSM ESMO - Eur. Oncology

#ELCC25 Mini Orals KRYSTAL7 trial: 1L adagrasib + pembro in KRASG12C+ PD-L1>50% NSCLC by Marina Garassino: - ORR 59%, DCR 81% - mPFS 27.7m In the PdL1 high subgroup of KN189, mPFS was 11.3m- so this is appears to be a signal ESMO - Eur. Oncology OncoAlert #LCSM

Update from KRYSTAL-7 by Marina Garassino Adagrasib + Pembrolizumab in 1L KRAS G12C NSCLC w/ PD-L1 ≥ 50% 🔹 ORR 59% with mDOR 26.3 mo 🔹 mPFS 27.7 mo 🔹 mOS Not Reached w/ median f/u 24.9mo 🔹 11-13% w/ G3 LFTs elevations in the overall cohort #ELCC25 #LCSM #LungCancer

KRAS mutation positive lung cancer, 1L therapies ? What should we do ? New outcomes, new questions. Marina Garassino Salman Punekar Marga Majem Prof. Dr. Adrianus Johannes De Langen ESMO - Eur. Oncology Lung Cancers Today #ELCC2025 #LCSM

Check provocative abstract 74P Andrea Torchia Flaura2 superior to Mariposa in EGFRex21 and CNS. ESMO - Eur. Oncology #ELCC2025 #ESMOAmbassadors

Session 4 at #TexasLung25 starts at 1:15 PM. Join Drs. Marina Garassino, Melina Marmarelis, Chul Kim, Loretta Erhunmwunsee, MD, FACS, Aaron Mansfield, Dr. Luis E. Raez, and Jennifer A. Marks, MD as they discuss rare thoracic tumors. hubs.la/Q03g5PQZ0

Insightful discussion on rare thoracic malignancies - thymoma/thymic carcinoma & mesothelioma at #TexasLung25. Challenging malignancies to diagnose and treat, often requiring sub-specialty and multi-d input.

Awesome closing to #TexasLung25 with live music 🎶 Hossein Borghaei, DO Marina Garassino Chul Kim Joshua Reuss TomMarron and others !!

Best community ever TLC Conference IASLC Stephen V Liu, MD

CHIP is a common, age-related condition where mutated blood stem cells expand without causing blood disorders. CHIP raises the risk of hematological malignancies, chronic inflammatory diseases (like heart & lung disease), & lung cancer. This manuscript shows that CHIP somatic

Please vote for Dr. Cascone MD Anderson Cancer Center She is an amazing: ✔️ Scientist ✔️ Oncologist ✔️ Human!!

PACIFIC-6 results from Marina Garassino now ESMO Open - phase II study of durvalumab after sequential chemoradiation for stage III NSCLC. PFS 13.1m, OS 39m, and 27% had G3/4 related AEs. While concurrent is our standard, not all are candidates. ESMO - Eur. Oncology esmoopen.com/article/S2059-…

Update of IMpower 010 Journal of Clinical Oncology. Adjuvant atezolizumab in resected NSCLC showed DFS HR 0.70 in stage II-IIIA PD-L1 positive. OS for stage II-IIIA was 0.77 in PD-L1+ and 0.47 in PD-L1 ≥50%. In stage II-IIIA, PD-L1 high, EGFR/ALK wt - 5y OS rate 82%. ascopubs.org/doi/10.1200/JC…

Excited for the #LCSM session today at #ASCO25! 🚨 Here’s the latest treatment algorithm for advanced/metastatic #NSCLC 👇 How will it change after today?🔥 Can’t wait to see where new agents & trial data may fit in! LungCancerRx 🫁💊 Hem-Onc Fellows Network @Oncoalert Oncology Brothers

So cool! Cough recorded with the app is different in lung cancer patients compared to healthy controls. arsela prelaj I3LUNG future applications are screening and CT scan outcomes! #acoustic #biomarkers #ASCO25

Party Who is who? third edition! #family #friendship #lungcancer #ASCO25 #chicago

A new Diary of an Oncology Leader video is out. In this episode, Marina Garassino shares her thoughts on her journey overseas, the founding of W4O Italy and the leadership lessons that shaped her path Watch now for inspiration 🔗 ow.ly/V6uV50Waztg #W4O #OncologyLeadership

Delighted to present episode 2 of ESMO - Eur. Oncology Women4Oncology’s Diary of an Oncology Leader, with Chair of Thoracic Oncology Marina Garassino from UniversityofChicago Great insights on: - role of community in skill-building - self belief - thinking big ‘Don’t wait. Just start’ OncoAlert #LCSM